Taken together, our analysis suggests the dependence of CRC tumors to the pro-survival Syk (L) isoform, except in the new identified subgroup of low PSI tumors in which gene reprograming has taken place to overcome the effect of Syk (L) down-regulation. The gene discussed is SYK; the disease is colorectal carcinoma.